Macquarie Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.69M | Buy |
+660,056
| New | +$7.69M | 0.01% | 869 |
|
|
2024
Q2 | – | Sell |
-121,185
| Closed | -$389K | – | 1893 |
|
|
2024
Q1 | $389K | Sell |
121,185
-2,113
| -2% | -$6.78K | ﹤0.01% | 1467 |
|
|
2023
Q4 | $604K | Buy |
123,298
+17,931
| +17% | +$87.8K | ﹤0.01% | 1445 |
|
|
2023
Q3 | $574K | Buy |
105,367
+2,055
| +2% | +$11.2K | ﹤0.01% | 1428 |
|
|
2023
Q2 | $693K | Buy |
103,312
+15,781
| +18% | +$106K | ﹤0.01% | 1413 |
|
|
2023
Q1 | $773K | Buy |
87,531
+29,655
| +51% | +$262K | ﹤0.01% | 1400 |
|
|
2022
Q4 | $442K | Sell |
57,876
-18,796
| -25% | -$144K | ﹤0.01% | 1531 |
|
|
2022
Q3 | $553K | Sell |
76,672
-1,323
| -2% | -$9.54K | ﹤0.01% | 1509 |
|
|
2022
Q2 | $631K | Sell |
77,995
-351
| -0.4% | -$2.84K | ﹤0.01% | 1565 |
|
|
2022
Q1 | $1.09K | Buy |
78,346
+3,546
| +5% | +$49 | ﹤0.01% | 1530 |
|
|
2021
Q4 | $2.1M | Buy |
74,800
+12,344
| +20% | +$346K | ﹤0.01% | 1359 |
|
|
2021
Q3 | $2.12M | Buy |
62,456
+7,394
| +13% | +$251K | ﹤0.01% | 1367 |
|
|
2021
Q2 | $2.25M | Buy |
55,062
+4,553
| +9% | +$186K | ﹤0.01% | 1379 |
|
|
2021
Q1 | $2.03M | Buy |
50,509
+10,847
| +27% | +$437K | ﹤0.01% | 1202 |
|
|
2020
Q4 | $2.35M | Sell |
39,662
-3,308
| -8% | -$196K | ﹤0.01% | 1062 |
|
|
2020
Q3 | $2.09M | Sell |
42,970
-3,151
| -7% | -$153K | ﹤0.01% | 1021 |
|
|
2020
Q2 | $2.23M | Buy |
46,121
+3,871
| +9% | +$187K | ﹤0.01% | 978 |
|
|
2020
Q1 | $1.17M | Buy |
42,250
+11,697
| +38% | +$325K | ﹤0.01% | 1050 |
|
|
2019
Q4 | $914K | Buy |
+30,553
| New | +$914K | ﹤0.01% | 1276 |
|